The AI in Business Podcast

• Leveraging Data to Scale Drug Development Globally - with Damion Nero of Takeda

  Today’s guest is Damion Nero, Head of Data Science at Takeda Pharmaceuticals. With over 15 years of experience applying AI, machine learning, and real-world data to drug development and precision medicine, Damion joins Emerj Managing Editor Matthew DeMello to explore the evolving role of AI in drug development and supply chain management. He breaks down how AI is currently streamlining administrative and regulatory tasks, improving efficiency across clinical trials, and saving valuable time for healthcare professionals. Damion also discusses why broader, transformative supply chain efficiencies are still on the horizon, as AI continues to evolve and scale in the pharmaceutical industry. This episode is sponsored by Arkestro. Learn more about Arkestro’s upcoming Advisory Council event here. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.

  --------  

  29:26
• Rethinking Customer Experiences with AI-Driven Conversations - with Alan Ranger of Cognigy

  With customer expectations at an all-time high, even one broken interaction can result in permanent brand damage. In this episode of ‘AI in Business,’ Cognigy Chief Marketing Officer Alan Ranger joins Emerj Editorial Director Matthew DeMello to explore how conversational, generative, and agentic AI are reshaping contact center strategy across telecom, retail, and financial services. Cognigy is a leading provider of AI-powered customer service solutions, offering an advanced platform that enables businesses to deliver instant, personalized, and multilingual support across various channels. Throughout the episode, Alan outlines the evolution from chatbots to co-pilots to fully agentic systems—and explains how these technologies are shifting enterprise workflows from task-based to value-driven service. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business’ podcast! This episode is sponsored by Cognigy. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

  --------  

  29:05
• The Evolving Role of AI in Modernizing Clinical Trials - with Xiong Liu of Novartis

  Today’s guest is Xiong Liu, Director of Data Science and AI at Novartis. Xiong returns to the platform in a special episode brought to you by Medable to explore the evolving role of AI in modernizing clinical trials. Their conversation covers how life sciences teams are leveraging AI to streamline data workflows, accelerate study readiness, and maintain regulatory compliance in both decentralized and traditional models. Throughout the episode, Xiong shares insights into the growing importance of integrating structured and unstructured data across trial systems — from clinical notes to imaging and lab results. This episode is sponsored by Medable. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business’ podcast!

  --------  

  28:29
• Driving Data Security in Unstructured and Structured Data for Customer Analytics - with Jiaxi Zhu of Google

  Today’s guest is Jiaxi Zhu, Head of Analytics & Insights at Google. Jiaxi joins Emerj Editorial Director Matthew DeMello to explore how enterprises can strengthen data security and governance as customer analytics increasingly relies on both structured and unstructured data. As organizations expand their use of sources like call transcripts, social media posts, and third-party platforms, traditional data protection models are no longer sufficient. Jiaxi explains how modernizing data governance with comprehensive data dictionaries and metadata management is essential for understanding data lineage and ensuring compliance. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business’ podcast!

  --------  

  26:21
• Laying the Groundwork for Enterprise AI in Banking and Finance - with Chris Tapley of EPAM

  Today’s guest is Chris Tapley, Vice President and Head of Financial Services Consulting for North America at EPAM Systems. EPAM is a global digital engineering company that provides software development and consulting services across industries, including financial services, healthcare, and media. With deep experience guiding AI adoption in regulated industries, Chris joins Emerj Editorial Director Matthew DeMello on the show today to unpack the foundational challenges facing financial institutions as they move from experimentation to production. He explores the technical and organizational barriers that often stall AI projects, from legacy systems and cloud limitations to gaps in data strategy and executive alignment. Chris shares lessons from EPAM’s recent market research on AI maturity in financial services — including how long it typically takes to establish enterprise-ready AI governance and why business leaders must prioritize infrastructure, collaboration, and oversight well before model deployment. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business’ podcast! This episode is sponsored by EPAM. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

  --------  

  42:49

More Technology podcasts

Trending Technology podcasts

About The AI in Business Podcast

The AI in Business Podcast: Podcasts in Family